Clinical trials
Active, not recruiting Phase 1/2 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Celgene | 2 |
| Mayo Clinic | 2 |
| AbbVie | 1 |
| CARsgen Therapeutics Co., Ltd. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Hackensack Meridian Health | 1 |
| Hellenic Society of Hematology | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 27 |
| Anemia, Aplastic | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Myelodysplastic Syndromes | 2 |
| Myeloproliferative Disorders | 2 |
| Recurrence | 2 |
| Bone Marrow Failure Disorders | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.